| Crystal structure of PTP1B D181A/Q262A phosphatase domain with a JAK3 activation loop phosphopeptide | |
Heteromer
P18031; | 979-982 | 100 | 1×PO4; 1×TRS; |
|
| Crystal structure of JAK3 in complex with peficitinib | | homo-2-mer | 815-1100 | 99.64 | 2×9T6; |
|
| Crystal structure of JAK3 in complex with Compound 10 (FM475) | | monomer | 812-1103 | 98.97 | 1×F3W; 1×PHU; 1×GOL; 7×EDO; |
|
| Crystal structure of JAK3 in complex with Compound 11 (FM481) | | monomer | 813-1103 | 98.96 | 1×F4B; 1×PHU; 6×EDO; |
|
| Crystal structure of JAK3 in complex with Compound 20 (FM484) | | monomer | 813-1103 | 98.96 | 1×F48; 1×PHU; 3×EDO; |
|
| Crystal structure of JAK3 in complex with FM587 (compound 9a) | | monomer | 813-1103 | 99.28 | 1×RQT; 1×PHU; 3×EDO; |
|
| Crystal structure of JAK3 in complex with Compound 4 (FM381) | | monomer | 814-1103 | 98.97 | 1×79T; 1×PHU; 6×EDO; |
|
| Crystal structure of JAK3 in complex with Compound 5 (FM409) | | monomer | 814-1103 | 98.97 | 1×PHU; 6×EDO; 1×79R; 1×79S; |
|
| Crystal structure of JAK3 in complex with FM601 (compound 10a) | | monomer | 814-1103 | 98.97 | 1×RQZ; 1×PHU; 5×EDO; |
|
| Crystal structure of JAK3 complexed with a potent ATP site inhibitor showing high selectivity withi… | | monomer | 815-1104 | 100.0 | 1×PJC; |
|
| Crystal structure of the Jak3 kinase domain in complex with a staurosporine analogue | | monomer | 814-1103 | 99.31 | 2×DTV; 1×4ST; |
|
| JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-2… | | monomer | 814-1103 | 99.64 | 1×19Q; |
|
| Crystal Structure of the Jak3 Kinase Domain Covalently Bound to N-(3-(((5-chloro-2-((2-methoxy-4-(4… | | monomer | 814-1103 | 99.63 | 1×4LH; |
|
| Crystal structure of JAK3 in complex with Delgocitinib | | monomer | 814-1102 | 100 | 1×FHX; |
|
| JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((R)-2… | | monomer | 814-1102 | 99.64 | 1×19R; |
|
| JAK3 kinase domain in complex with 1-[(3S)-1-isobutylsulfonyl-3-piperidyl]-3-(5H-pyrrolo[2,3-b]pyra… | | monomer | 814-1102 | 99.64 | 1×3C9; |
|
| JAK3 kinase domain in complex with 2-Phenoxy-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1-cyc… | | monomer | 815-1102 | 99.64 | 1×PHU; 1×1DT; |
|
| JAK3 with cyanamide CP12 | | monomer | 814-1100 | 99.63 | 1×HB4; 1×SO4; |
|
| JAK3 with Cyanamide CP34 | | monomer | 814-1100 | 99.64 | 1×G4Y; |
|
| HUMAN JAK3 KINASE DOMAIN WITH 1-(4-((2-((1-methyl-1H-pyrazol-4-yl)amino)quinazolin-8-yl)amino)piper… | | monomer | 814-1100 | 99.64 | 1×934; 1×SO4; 1×PHU; |
|
| Crystal structure of Jak3 complexed to N-[3-(6-Phenylamino-pyrazin-2-yl)-3H-benzoimidazol-5-yl]-acr… | | monomer | 814-1100 | 98.89 | 1×37Q; |
|
| JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1… | | monomer | 815-1101 | 99.64 | 1×PHU; 1×933; |
|
| Jak3 with covalent inhibitor 6 | | monomer | 814-1100 | 99.64 | 1×7KX; |
|
| JAK3 with Cyanamide CP23 | | monomer | 814-1100 | 99.64 | 1×G54; |
|
| Crystal structure of JAK3 kinase domain in complex with compound 25 | | monomer | 814-1100 | 99.64 | 1×OV5; |
|
| Jak3 with covalent inhibitor 4 | | monomer | 814-1100 | 99.64 | 1×7KU; |
|
| JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((R)-1… | | monomer | 815-1101 | 99.64 | 1×19S; |
|
| Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inh… | | monomer | 814-1100 | 99.28 | 1×VFC; 1×PEG; 3×CL; |
|
| JAK3 with covalent inhibitor PF-06651600 | | monomer | 815-1100 | 99.64 | 1×7H4; 1×SO4; |
|
| Jak3 with covalent inhibitor 7 | | monomer | 815-1099 | 99.63 | 1×7KV; 2×SO4; |
|
| Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with C… | | monomer | 814-1098 | 99.64 | 1×IZA; |
|
| Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor | | monomer | 815-1099 | 99.28 | 1×Z3A; |
|
| Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor | | monomer | 814-1098 | 99.28 | 1×1NX; |
|
| CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7) | | monomer | 814-1098 | 99.26 | 1×9YV; |
|
| CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE INHIBITOR | | monomer | 815-1099 | 99.63 | 1×9J4; |
|
| Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor | | monomer | 815-1099 | 99.3 | 1×3QX; |
|
| JAK3 with Cyanamide CP10 | | monomer | 815-1099 | 99.64 | 1×G4V; |
|
| Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with C… | | monomer | 815-1098 | 99.64 | 1×MI1; |
|
| HUMAN JAK3 IN COMPLEX WITH LASW959 PROTEIN IN COMPLEX WITH LIGAND | | monomer | 815-1098 | 99.62 | 1×GYW; |
|
| THE JAK3 KINASE DOMAIN IN COMPLEX WITH A COVALENT INHIBITOR | | monomer | 817-1099 | 99.62 | 1×9Z4; |
|
| JAK3 in complex with a covalent EGFR inhibitor | | monomer | 817-1098 | 99.63 | 1×G9B; |
|